Compare · AXP vs CELZ
AXP vs CELZ
Side-by-side comparison of American Express Company (AXP) and Creative Medical Technology Holdings Inc. (CELZ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXP and CELZ operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- AXP is the larger of the two at $215.39B, about 25333.1x CELZ ($8.5M).
- Over the past year, AXP is up 18.5% and CELZ is up 13.1% - AXP leads by 5.5 points.
- AXP has been more active in the news (10 items in the past 4 weeks vs 1 for CELZ).
- AXP has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- American Express Company
- Creative Medical Technology Holdings Inc.
- Price
- $314.00-1.42%
- $2.25-2.60%
- Market cap
- $215.39B
- $8.5M
- 1M return
- +4.63%
- +19.68%
- 1Y return
- +18.52%
- +13.07%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 10
- 1
- Recent ratings
- 25
- 1
American Express Company
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Latest AXP
- SEC Form IRANNOTICE filed by American Express Company
- SEC Form 10-Q filed by American Express Company
- American Express Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- American Express Reports First-Quarter 2026 Financial Results
- American Express Debuts New Membership Experiences at the 2026 NFL Draft
- American Express Canada and DMZ's Grant Program Returns to Support Canadian Small Business
- American Express to Acquire Hyper, Adding to Its AI Expertise and Expense Management Capabilities
- American Express Company filed SEC Form 8-K: Regulation FD Disclosure
- American Express Debuts Agentic Commerce Experiences (ACE)™ Developer Kit and Announces Industry-First Protection for Registered Agent Purchases
- SEC Form 4 filed by Wallace Noel R.
Latest CELZ
- Amendment: SEC Form 10-K/A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-K filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.